Corporate Update

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it has raised $1.1m in new capital in

Supplementary Prospectus

This is a supplementary prospectus (Supplementary Prospectus) which is intended to be read with the prospectus dated 24 July 2024 (Prospectus) issued